Objective: In achalasia, absent peristalsis and reduced esophagogastric junction (EGJ) relaxation and compliance underlie dysphagia symptoms. Novel high-resolution impedance manometry variables, that is, bolus presence time (BPT) and trans-EGJ-bolus flow time (BFT) have been developed to estimate the duration of EGJ opening and trans-EGJ bolus flow. The aim of this study was to evaluate esophageal motor function and bolus flow in children diagnosed with achalasia using these variables. Methods: High-resolution impedance manometry recordings from 20 children who fulfilled the Chicago Classification (V3) criteria for achalasia were compared with recordings of 15 children with normal esophageal highresolution manometry findings and no other evidence suggestive of achalasia. Matlab-based analysis software was used to calculate BPT and BFT. Results: Both BPT and BFT were significantly reduced in achalasia patients compared with children with normal esophageal motility (BPT 3.3 s vs 5.1 s P < 0.01; BFT 1.4 s vs 4.3 s P < 0.001). BFT was significantly lower than BPT (achalasia difference 1.9 s AE 1.3 s, P ¼ 0.001 and normal difference 0.9 AE 0.3 s, P ¼ 0.001). Overall, there was a significant correlation between BPT and BFT (r ¼ 0.825, P < 0.001). We observed a 2-way differentiation of achalasia patients; those in whom the BPT and BFT were proportional, but significantly lower than in patients with normal peristalsis, and those in whom BFT was disproportionately lower than BPT. Conclusions: Calculation of BPT and BFT may help determine whether esophageal bolus transport to the EGJ and/or esophageal emptying through the EGJ are aberrant. For achalasia, this may detect flow resistance at the EGJ, potentially improving both diagnosis and objective assessment of therapeutic effects.
A chalasia is an uncommon esophageal motility disorder, with an estimated annual incidence of 0.01 to 0.11 per 100,000 children (1, 2) . It is characterized by failure of relaxation of the lower esophageal sphincter (LES) and absence of peristalsis in the distal esophagus both of which lead to slow or absent bolus transit which results in symptoms of dysphagia, obstruction, chest pain, regurgitation, respiratory symptoms (chronic and nocturnal cough, aspiration), and weight loss (2) (3) (4) .
In children and adults, the diagnosis of achalasia is based on the combination of the clinical picture, radiographic findings and the results of high-resolution esophageal manometry (HRM). The latter is currently considered the criterion standard for diagnosing and subtyping achalasia (5) . According to the recently published Chicago Classification (CC; version 3.0), 3 subtypes are defined, all requiring a mean integrated relaxation pressure (IRP4s) >15 mmHg (4) . This heavy reliance is potentially problematic. The IRP4s is a complex metric, not only depending on the adequacy of LES relaxation, crural diaphragm contraction, and esophagogastric junction (EGJ) opening, but also on the pattern and timing of distal esophageal contractility. In clinical practice, instances of clinically evident achalasia with IRP4s <15 mmHg do exist, especially in type I achalasia patients with low intraesophageal pressures and type II achalasia patients with short periods of panesophageal pressurizations (4, 6) .
To overcome these limitations, a new approach has been developed using combined pressure and impedance to estimate the
What Is Known
The diagnosis of achalasia is based on the combination of clinical history, radiography and high-resolution esophageal manometry. By integrating impedance to high-resolution esophageal manometry, a new approach has been developed to estimate the duration of bolus presence time and trans-esophagogastric junction bolus flow time. In adults, bolus presence time and bolus flow time have shown to be discriminative in equivocal achalasia cases.
What Is New
In this pediatric study, bolus presence time and bolus flow time were significantly reduced in achalasia patients compared with children with normal esophageal motility. Integrated pressure-flow analysis may aid in pediatric achalasia management, particularly given the frequent discordance between symptoms and esophageal function testing.
duration of trans-EGJ-flow (7) (8) (9) . In adult achalasia patients, trans-EGJ-bolus flow time (BFT) was significantly reduced in all achalasia subtypes and correlated with dysphagia severity (8) . We hypothesized that the BFT could also be applied to better diagnose pediatric achalasia, by detecting impaired bolus flow and thereby complementing the IRP4s to discriminate in equivocal cases. Therefore, the aim of this study was to apply novel pressure impedance parameters to a cohort of children diagnosed with achalasia according to the CC V3.0 and to compare them with children referred for diagnostic high-resolution impedance manometry (HRIM), but with normal esophageal motility and no other evidence of achalasia (4) .
METHODS
Combined HRIM recordings of 20 consecutive pediatric achalasia patients (clinical diagnosis and fulfilling CC V3.0 criteria on HRM) and 15 patients who fulfilled criteria for normal esophageal motility and had no signs of achalasia during endoscopy and/or timed barium swallow, were extracted from a clinical database at the Boston Children's Hospital (Boston, MA). Studies were performed between September 2010 and June 2016. Studies were only selected if patients were <21 years at time of HRIM investigation; we did not apply a lower age-limit. All included patients underwent clinical diagnostic HRIM to investigate dysphagia and/or gastroesophageal reflux related symptoms. All of the patients with achalasia had a nonequivocal diagnosis based on clinical symptoms, radiographic and manometric values. Some achalasia patients were studied after initial therapy (ie, pneumatic dilation, thoracoscopic Heller myotomy) because of persistent symptoms. The CC was used to diagnose and classify the subtypes of achalasia patients. Clinical data, including predominant symptom subtype and medication use, were extracted by chart review and are reported for all patients. The study was approved by the Boston Children's Hospital Institutional Review Board.
High-Resolution Impedance Manometry Recording
All of the subjects fasted for at least 8 hours for solids, and 4 hours for liquids before the study and were studied off esophageal motility influencing drugs. Depending on patient's age and height, a 3.2 or 4.2 mm diameter solid-state HRIM catheter was used incorporating, respectively, 36 1 cm-spaced pressure sensors and 18 adjoining 2 cm impedance segments (Given Imaging, Los Angeles, CA). Patients were studied sitting in the supine or semisupine position with a standard protocol including 10 swallows of 5 mL saline administered via a syringe at !30 s intervals. Studies were considered for inclusion if they met the following criteria: !10 saline liquid swallows performed, adequate catheter position to measure EGJ pressures, and no technical errors, such as, pressure or impedance channel failure. Individual swallows were excluded from analysis if bolus passage into the proximal esophagus was not clearly discernible on the impedance recording, or if secondary swallows overlapped and inhibited the propagating pressure wave.
Data Analysis
Objective swallow data were evaluated by using purposed designed software (AIMplot copyright T.I. Omari; MATLAB v5.0 2015; MathWorks Inc, Natick, MA) and by pressure topography analysis using the Chicago Classification (V3.0) using ManoView 3.0 analysis software (Given Imaging, Los Angeles, CA). All of the studies were blindly reviewed. To perform pressure-flow analysis (PFA), raw pressure-impedance data for all swallows were visualized for a 30-second window and exported from the recording system in text (.txt) format. The calculations used to derive PFA metrics have been previously described (10, 11) . In brief, pressure impedance recordings are displayed as pressure topography plots with embedded impedance recordings which show bolus flow movements and relaxation and movement of the upper and LES pressure zones. On selection of specific landmarks on the pressure topography space-time plot, specific spatial and temporal regions of interest are mapped. Data for 3 pressure-flow variables are presented, these are Peak Pressure, defined as the pressure at maximum contraction, Intra-Bolus Distension Pressure defined as the pressure at nadir impedance, and the Impedance Ratio, defined by the ratio of nadir impedance to peak pressure impedance (10) . As the algorithm used to derive these variables requires identification of an esophageal pressure peak, they could not be derived for those patients with achalasia type I. As only 1 patient had achalasia type III, only the grouped data for those patients with achalasia type II (both treated and untreated) and patients with normal esophageal motility are shown. Unless otherwise indicated, these variables are displayed as mean values for the distal esophagus from transition zone to EGJ. In cases where the transition zone was not visible, the distal two-thirds of the esophageal tracing was used.
Using the impedance signals, first, potential regions of bolus presence within the EGJ were defined as the intervals during which there was an impedance drop >50% when compared with baseline, as previously described (7). The duration of bolus presence within the EGJ (bolus presence time [BPT]) was determined, with the onset of bolus presence defined as the point at which the impedance dropped 90% relative to baseline impedance and the offset as the return to 50%. The trans-EGJ-BFT was calculated by summing all periods fulfilling the criteria of BPT, and subtracting time periods of crural contraction (7, 8) . The difference between BFT and BPT was additionally calculated. As previously described, we used the ratio of BFT and BPT (BFT/BPT) to define the effectiveness of trans-EGJ emptying relative to the period of bolus presence (ie, ratio of 1 means unrestricted trans-EGJ flow, ratio of 0.5 means that flow was estimated to occur during only half the time that bolus was present) (7, 8) . The 10th percentile of BFT and BPT in patients with normal esophageal HRM findings were used to define ranges of normality.
Statistical Analysis
Distribution of data was evaluated using the KolmogorovSmirnov test. Parametric data are expressed as mean AE standard deviation (SD), and nonparametric data as median, interquartile range (IQR). Mann-Whitney U test or t test and Analysis Of Variance (ANOVA) or Kruskal-Wallis tests were used to compare mean or median values of continuous outcomes, respectively, between patients with normal motility and achalasia patients and across achalasia subtypes. Tukey's adjustment for multiple pairwise comparisons was used to examine pairwise differences (eg, across patient groups and across achalasia subtypes). Bivariate associations between continuous variables were evaluated via Pearson's sample correlation coefficients and/or Spearman's sample correlation coefficients in cases of possible violation of relevant statistical assumptions. Statistical tests were performed using IBM SPSS Statistics 23 (SPSS Inc, Chicago, IL). Differences were considered statistically significant when P < 0.05.
RESULTS

Patient Characteristics
Patient characteristics are displayed in Supplemental Digital Content, Table 1 , http://links.lww.com/MPG/B17. Fifteen patients were diagnosed with type II achalasia, 5 with type I and 2 with type III. Seven of the achalasia patients were studied postintervention (ie, balloon dilatation and/or thoracoscopic Heller myotomy), of whom 2 patients (both type II achalasia) had also been studied before treatment. As these patients were included in both the preand postintervention groups, a total number of 22 HRIM tracings were analyzed. All of the patients who were studied postintervention, were studied due to persisting dysphagia symptoms. Of these 7 patients, 2 were type I, 4 were type II and 1 was type III. In 1 patient, prior fundoplication was undone before myotomy.
Comparison of Esophagogastric Junction Parameters
Comparisons of parameters measured at the EGJ between the 3 patient groups and among achalasia subtypes are presented in Table 1 . Integrated relaxation pressure (IRP4s) was significantly lower in the patients with normal motility and treated achalasia patients compared with the untreated achalasia patients (adjusted P < 0.001 and P ¼ 0.014), but did not differ between treated achalasia patients and patients with normal motility ( Fig. 1 ; adjusted P ¼ 0.892). Patients with normal motility had significantly higher BFT (adjusted P < 0.001 and P ¼ 0.020, respectively) and BPT (adjusted P ¼ 0.001 and P ¼ 0.020) when compared with the untreated and treated achalasia patients. There was no difference in BFT and BPT between treated and untreated achalasia patients P < 0.05, aa,bb,cc P < 0.01, aaa,bbb,ccc P < 0.001).
FIGURE 1.
Esophagogastric junction (EGJ) parameters in achalasia patients (all subtypes) and patients with normal motility. In symptomatic treated achalasia patients, integrated relaxation pressure (IRP4s) normalized to the level seen in patients with normal motility, reflecting the effect of dilation therapy on the lower esophageal sphincter (LES). Bolus flow time (BFT) and bolus presence time (BPT) were significantly reduced in both symptomatic treated and untreated achalasia patients when compared with patients with normal motility, but not between treated and untreated achalasia patients. This may potentially reflect that the treated achalasia patients were presenting with refractory symptoms, suggesting that BFT and BPT may actually correspond with the clinical impact of therapy.
(adjusted P ¼ 0.662 and P ¼ 1.000, respectively). None of the 3 EGJ parameters were found to correlate significantly with patients' age, height, or weight (overall and subgroup analysis).
Comparisons of Pressure-flow Analysis Characteristics (Normal Motility and Achalasia Type II Only)
Comparisons of PFA characteristics between patients with achalasia type II and patients with normal motility are presented in Table 2 . There were no significant differences in distension pressures or impedance ratio between the untreated and treated achalasia type II patients. When compared with patients with normal motility, we found lower peak pressures (adjusted P ¼ 0.001 and P ¼ 0.032, respectively), and higher distension pressures (adjusted P < 0.001 and P ¼ 0.020, respectively) in patients with untreated and treated achalasia. The impedance ratio was higher in patients with untreated achalasia (adjusted P < 0.001) suggesting greater bolus residual.
Concordance Between Integrated Relaxation Pressure, Bolus Flow Time, and Bolus Presence Time
Overall, there was a significant correlation between IRP4s and BFT, IRP4s and BPT, and between BFT and BPT ( Fig. 2; Spearman's r ¼ À0.638, P < 0.001; r ¼ À0.358, P ¼ 0.030 and r ¼ 0.825, P < 0.001). There was a significant correlation between BPT and BFT for children with normal motility (Spearman's r ¼ 0.961, P < 0.001) and for treated achalasia patients (Spearman's r ¼ 0.811, P ¼ 0.027). Only a weak trend was noted for untreated achalasia patients (r ¼ 0.468, P ¼ 0.078).
As shown in Fig. 2 , patients with normal motility showed a linear relationship between BPT and BFT and had a BFT/BPT ratio !0.5, estimating trans-EGJ-flow to occur during at least half the time that the bolus was present. In contrast, achalasia patients appeared to separate into 2 groups: those in whom the BPT and BFT were proportional, but significantly lower than patients with normal peristalsis (ie, BFT/BPT ratio !0.5 and BPT OR BPT <10th percentile of patients with normal motility); and those in whom BFT was disproportionately lower than BPT (BFT/BPT ratio <0.5). Patients in Group 2 appeared to have evidence of greater distal flow resistance as indicated by a significantly higher IRP4s and higher PFI compared with patients in Group 1 (P ¼ 0.028 and P < 0.001, respectively). Untreated type 2 achalasia patients were more often in Group 2 (64%) compared with Group 1 (36%); however, this was not a statistically significant proportion (Fisher exact test statistic 0.395). One of the treated achalasia type II patients who underwent HRIM study twice due to persisting dysphagia symptoms was initially in Group 2 and shifted to Group 1 at repeat analysis postintervention, suggesting that therapy had been ineffective, even though the IRP4s had normalized (40.2-6.6 mmHg). The other treated patient, that was first in Group 1, showed similar BFT and BPT characteristics at repeat analysis postintervention as patients with normal motility, although dysphagia symptoms persisted in this patient.
Esophageal Emptying, Pressurization, and Trans-Esophagogastric Junction Flow
Overall, there was a significant negative correlation between impedance ratio and BPT and BFT (Spearman's r ¼ À0.603, P < 0.001 and r ¼ À0.760, P < 0.001, respectively). There was also a significant overall negative correlation between distension pressure and BPT/BFT (r ¼ À0.326/À6.616, P ¼ 0.049/<0.001). Patients in Group 2 had significantly higher distension pressures when compared with patients with normal peristalsis (20.2 (17.2-23.4) mmHg vs 7.4 (4.6-11.1) mmHg; adjusted P < 0.001). There were no significant differences in between patients in Group 1 (11. 6 (7.9-17.1) mmHg) and patients in Group 2 (P ¼ 0.105) or patients with normal motility (P ¼ 0.083 and P ¼ 0.128, respectively). The impedance ratio was significantly lower in patients with normal motility (0.29 (0.19-0.39)) when compared with patients in Group 1 (0.79 (0.45-0.90); P ¼ 0.001) and Group 2 (0.80 (0.62-0.87); P < 0.001)), but did not differ significantly between Groups 1 and 2 (P ¼ 1.000).
DISCUSSION
The aim of this study was to evaluate esophageal motor function in children diagnosed with achalasia using novel esophageal pressure-flow variables. Our findings support that in children, some metrics measured at the EGJ, BFT in particular, provide added information on EGJ outflow obstruction, as was previously shown in adults (7, 8) . BFT integrates measures of EGJ opening (impedance) and pressure to predict when trans-EGJ bolus flow is occurring, thereby providing a more comprehensive evaluation of EGJ function than the (pressure only) IRP4s.
In our cohort, both BFT and BPT were significantly lower in achalasia patients compared with patients with normal esophageal motility. Consistent with the known effect of dilation therapy, the IRP4s was significantly lower in patients postintervention ( Fig. 1 ) (12) . Unlike IRP4s, BFT and BPT were, however, not significantly different in the treated group when compared with the untreated group. This is consistent with the fact that the treated achalasia patients were presenting with persistent symptoms. Although this suggests that the BFT may actually correspond with the clinical impact of therapy, our study did not include patients who responded to therapy and therefore cannot fully address this question. A recent study prospectively followed a cohort of 75 achalasia patients after pneumotic dilatation or Heller myotomy and found that BFT correlated better with clinical and radiographic treatment outcome as compared to IRP4s (13). 
The CC and its metrics have been developed to characterize specific features of deglutitive esophageal function and classify motility disorders in a hierarchical fashion, based upon data from healthy adults (4) . Because of the lack of established age-appropriate reference ranges for the metrics, which drive the CC, corroboratory evidence in support of a CC diagnosis is particularly important in children. In a previous study, we found younger age to correlate significantly with higher IRP4s, potentially leading to the overdiagnosis of achalasia and other IRP4s-driven CC diagnoses, when fixed cut-off values are applied. Parameters such as the impedance ratio, and the esophageal impedance integral ratio (not investigated here), may have additive value by defining the degree and extent of bolus retention over multiple swallows (14) . In addition, distension pressures were higher among achalasia patients and were negatively correlated with BFT, consistent with flow resistance during esophageal emptying (12) .
Overall, we found significant correlation between BFT and BPT and observed a 2-way differentiation of achalasia patients; those in whom the BPT and BFT were proportional, but significantly lower than in patients with normal peristalsis (Group 1), and those in whom BFT was disproportionately lower than BPT (Group 2). Patients in both Group 1 and 2 showed significantly higher impedance ratio when compared with patients with normal motility and patients in Group 2 also showed significantly higher distension pressures. These data suggest, conceptually, that the BFT to BPT relationship may help stratify patients with a disproportionately reduced BFT as a marker of outflow resistance and patients with the ability to generate sufficient intraesophageal pressure to establish a flow-permissive gradient across the EGJ. Further studies are, however, needed to explore the effect of therapy on individual patients characterized in this way.
To our knowledge, no other study has specifically investigated pressure-impedance characteristics in a cohort of pediatric achalasia patients. This work has limitations as it requires both HRIM recordings and MATLAB programming, thereby making it not widely available. The analysis technique still requires identification of appropriate landmarks and will be subject to the expertise of the interpreter in localizing these landmarks. Its automation and objectivity in the derivation of additional functional measures of bolus movement in relation to esophageal and EGJ pressurization, however, may complement a pressure-only derived diagnosis of achalasia and its subtypes. We recognize the limitations of a retrospective cohort study with sometimes incomplete clinical data, particularly in relation to symptom severity. As age of included patients ranged from 8 to 21 years old at the time of HRIM investigation, it is not sure whether results could be extrapolated to a younger achalasia population. Furthermore, our patients with normal motility are not equivalent to healthy controls, the achalasia cohort was heterogeneous and specific pediatric validation studies of the parameters used to characterize EGJ outflow resistance have not been performed. In addition, our cohort only included 2 patients that were studied both pre-and postintervention due to persisting symptoms. As a result, we were unable to evaluate parameters in relation to treatment success.
In summary, in pediatric achalasia patients, novel integrated pressure-flow variables may have additional value for diagnostic assessment and monitoring of therapeutic efficacy. Of the variables assessed in this study, the BFT parameter and its relationship with bolus presence within the EGJ may have clinical value by stratifying patients with a disproportionately reduced BFT as a marker of outflow resistance. Our study suggests that an improved HRIM evaluation using integrated pressure-flow criteria would better aid in pediatric achalasia management decisions, particularly given the frequent discordance between symptomatic and objective measures of esophageal function. Further studies are, however, needed to correlate these parameters with symptom severity before and after therapy.
